Q3 2024 EPS Estimates for Jacobs Solutions Inc. Reduced by William Blair (NYSE:J)

Jacobs Solutions Inc. (NYSE:J) – Stock analysts at William Blair decreased their Q3 2024 earnings estimates for Jacobs Solutions in a research report issued to clients and investors on Wednesday, May 8th. William Blair analyst L. Dipalma now anticipates that the company will post earnings per share of $2.03 for the quarter, down from their previous estimate of $2.10. William Blair currently has a “Market Perform” rating on the stock. The consensus estimate for Jacobs Solutions’ current full-year earnings is $8.07 per share. William Blair also issued estimates for Jacobs Solutions’ Q4 2024 earnings at $2.09 EPS and FY2024 earnings at $8.05 EPS.

Jacobs Solutions (NYSE:J) last released its quarterly earnings results on Tuesday, May 7th. The company reported $1.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.84 by $0.07. The firm had revenue of $4.27 billion during the quarter, compared to the consensus estimate of $4.33 billion. Jacobs Solutions had a net margin of 4.20% and a return on equity of 14.57%. The company’s revenue for the quarter was up 4.7% on a year-over-year basis. During the same quarter last year, the firm earned $1.81 earnings per share.

A number of other brokerages also recently weighed in on J. Truist Financial lowered their target price on shares of Jacobs Solutions from $154.00 to $153.00 and set a “hold” rating for the company in a research note on Wednesday. Bank of America lifted their target price on shares of Jacobs Solutions from $145.00 to $152.00 and gave the stock a “neutral” rating in a research note on Tuesday, April 2nd. Argus lifted their target price on shares of Jacobs Solutions from $161.00 to $174.00 and gave the stock a “buy” rating in a research note on Thursday, March 14th. Citigroup lifted their target price on shares of Jacobs Solutions from $161.00 to $169.00 and gave the stock a “buy” rating in a research note on Monday, April 22nd. Finally, Royal Bank of Canada lifted their price target on shares of Jacobs Solutions from $151.00 to $161.00 and gave the company an “outperform” rating in a research note on Wednesday, February 7th. Six research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $156.25.

Jacobs Solutions Price Performance

J stock opened at $139.79 on Thursday. Jacobs Solutions has a 52-week low of $109.00 and a 52-week high of $154.50. The company has a fifty day moving average price of $147.17 and a 200-day moving average price of $138.31. The company has a market capitalization of $17.56 billion, a P/E ratio of 26.99, a PEG ratio of 1.57 and a beta of 0.74. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.37 and a current ratio of 1.37.

Institutional Trading of Jacobs Solutions

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. First Pacific Financial purchased a new stake in shares of Jacobs Solutions in the 4th quarter valued at $27,000. GAMMA Investing LLC purchased a new stake in shares of Jacobs Solutions in the 4th quarter valued at $27,000. ICA Group Wealth Management LLC purchased a new stake in shares of Jacobs Solutions in the 4th quarter valued at $30,000. Union Savings Bank boosted its stake in shares of Jacobs Solutions by 78.1% in the 4th quarter. Union Savings Bank now owns 285 shares of the company’s stock valued at $37,000 after purchasing an additional 125 shares in the last quarter. Finally, Northwest Financial Advisors purchased a new stake in shares of Jacobs Solutions in the 4th quarter valued at $39,000. Institutional investors own 85.65% of the company’s stock.

Insider Activity

In other news, CFO Kevin C. Berryman sold 1,500 shares of Jacobs Solutions stock in a transaction dated Monday, April 1st. The shares were sold at an average price of $153.20, for a total transaction of $229,800.00. Following the completion of the transaction, the chief financial officer now directly owns 233,104 shares in the company, valued at $35,711,532.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, insider Steven J. Demetriou sold 7,000 shares of the business’s stock in a transaction dated Monday, April 1st. The shares were sold at an average price of $153.20, for a total transaction of $1,072,400.00. Following the transaction, the insider now directly owns 555,138 shares in the company, valued at $85,047,141.60. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO Kevin C. Berryman sold 1,500 shares of the business’s stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $153.20, for a total transaction of $229,800.00. Following the transaction, the chief financial officer now owns 233,104 shares in the company, valued at $35,711,532.80. The disclosure for this sale can be found here. Insiders sold 24,338 shares of company stock worth $3,618,695 over the last three months. 1.00% of the stock is currently owned by insiders.

Jacobs Solutions Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 21st. Stockholders of record on Friday, May 24th will be issued a dividend of $0.29 per share. This represents a $1.16 dividend on an annualized basis and a dividend yield of 0.83%. The ex-dividend date is Thursday, May 23rd. Jacobs Solutions’s dividend payout ratio is currently 22.39%.

About Jacobs Solutions

Jacobs Solutions Inc provides consulting, technical, engineering, scientific, and project delivery services for the government and private sectors in the United States, Europe, Canada, India, Asia, Australia, New Zealand, the Middle East, and Africa. It operates through Critical Mission Solutions, People & Places Solutions, Divergent Solutions, and PA Consulting segments.